Brief: Biora Therapeutics Announces New Patent For Its Navicap™ Targeted Oral Delivery Platform
19/12/2023 13:08
Dec 19 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS ANNOUNCES NEW PATENT FOR ITS NAVICAP™
TARGETED ORAL DELIVERY PLATFORM
Source text for Eikon: ID:nGNX65Cw72
Further company coverage: BIOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules